The Market Is Panicking, But You Should Keep Buying Shares of This Artificial Intelligence (AI) Powerhouse

Broadcom’s AI semiconductor revenue reached $10.8 billion in the latest quarter, up 143% year over year, and management expects the business to top $100 billion in revenue in 2027 as custom AI chips move into production. The article argues the recent stock selloff is an opportunity to buy the dip, citing Alphabet, Meta, Anthropic, and OpenAI as key customers. Overall tone is constructive on Broadcom’s long-term AI growth trajectory despite near-term volatility.

Analysis

The market is treating AVGO like a near-term AI spend proxy, but the real setup is a timing mismatch: the equity is discounting a multi-quarter digestion period while the earnings power inflects later, when custom silicon moves from pilot to volume. That creates a classic second-order opportunity for funds that can tolerate 6-18 months of dead money: the business mix shifts toward higher-visibility, lower-competition revenue streams just as sentiment is still anchored to the last-quarter miss.

The more important competitive dynamic is not AVGO versus chip peers, but AVGO versus the economics of GPU-heavy AI infrastructure. If hyperscalers can prove that application-specific silicon lowers inference cost enough to materially expand internal AI usage, the demand curve becomes self-reinforcing and Broadcom’s share of wallet rises without requiring the same level of external capex growth. That also indirectly pressures GPU vendors and any AI software names whose unit economics depend on expensive compute; cheaper compute broadens adoption, but it also narrows the moat for companies selling compute as a service.

The contrarian miss in the market is that 2027 is not just a revenue year, it is a credibility year. If a few of the named customers hit production milestones, AVGO likely de-risks the entire “custom AI” category and rerates on visibility rather than just growth. The risk is that the timeline slips even one cycle: because the stock has already been punished, another delay would force momentum funds and crowded AI longs to de-gross, creating a sharper drawdown than fundamentals alone would justify.

Key Decisions for Investors

• Buy AVGO on further weakness with a 6-12 month horizon; best entry is on post-earnings or broad AI selloff tape, targeting a 15-20% rebound if the market starts pricing 2027 visibility again.
• Pair long AVGO / short NVDA for a 3-6 month relative-value trade: AVGO benefits from custom silicon adoption while NVDA carries more multiple risk if AI capex rotates from generalized GPUs toward application-specific chips.
• Use call spreads in AVGO rather than outright stock for event risk control: a 9-12 month bull call spread captures rerating potential while limiting downside if customer timelines slip.
• If you own META or GOOGL, treat AVGO weakness as a confirmation signal rather than a negative read-through; add to AVGO only when hyperscaler capex commentary stays intact, because that is the real catalyst for the custom chip thesis.